0001140361-18-041597.txt : 20181030 0001140361-18-041597.hdr.sgml : 20181030 20181030100013 ACCESSION NUMBER: 0001140361-18-041597 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181026 FILED AS OF DATE: 20181030 DATE AS OF CHANGE: 20181030 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coelho Mary Theresa CENTRAL INDEX KEY: 0001720772 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13648 FILM NUMBER: 181145722 MAIL ADDRESS: STREET 1: 52 SUNRISE PARK ROAD CITY: NEW HAMPTON STATE: NY ZIP: 43017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BALCHEM CORP CENTRAL INDEX KEY: 0000009326 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 132578432 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P O BOX 600 CITY: NEW HAMPTON STATE: NY ZIP: 10958 BUSINESS PHONE: 8453265632 MAIL ADDRESS: STREET 1: P O BOX 600 CITY: NEW HAMPTON STATE: NY ZIP: 10958 4 1 form4.xml FORM 4 X0306 4 2018-10-26 0000009326 BALCHEM CORP BCPC 0001720772 Coelho Mary Theresa C/O BALCHEM CORPORATION 52 SUNRISE PARK ROAD NEW HAMPTON NY 10958 true Chief Financial Officer Common Stock 2018-10-29 4 F 0 1187 96.42 D 2105 D Employee Stock Option (Right to Buy) 74.57 2018-10-26 4 A 0 1132 0 A 2018-10-26 2028-02-15 Common Stock 1132 3337 D The Company granted 5,605 restricted shares under the Company's Long-Term Incentive Program. The shares were subject to certain restrictions under the applicable Restricted Stock Grant Agreements. 1,187 of the 3,210 shares that vested October 26, 2018 were withheld to cover withholding taxes due upon vesting. In connection with a Separation Agreement and General Release (SA&GR) between the Company and the reporting person, 1,050 shares previously reported as beneficially owned in connection with Restricted Stock Grant Agreements were forfeited. On February 15, 2018, the reporting person was granted an option to purchase 5,030 shares of common stock scheduled to vest in installments of 20%, 40%, and 40% per year over the three-year period. The option reported herein as acquired resulted from the acceleration of vesting of 22.5% of such option in connection with a SA&GR. /s/ Mary Theresa Coelho, by Attorney in Fact, Mark Stach 2018-10-29